Author

Mikaela Dicome

University of New MexicoORCID 0000-0001-8713-5677Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Avinash D SahuiD· 2 shared Luis E. Tafoya· 2 shared Ala JararwehiD· 1 shared David ArredondoiD· 1 shared Deepali L. KundnaniiD· 1 shared Genevieve Marie BolandiD· 1 shared Keith T. FlahertyiD· 1 shared Kushal Virupakshappa· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Avinash D SahuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 1, 2026

Tumor γδ T-cell abundance is associated with favorable cancer treatment outcomes

Xingzhi Niu, Deepali L. Kundnani, Mikaela Dicome…·Avinash D Sahu

This study finds that higher pretreatment γδ T-cell abundance is linked to better outcomes in cancer patients receiving immune checkpoint blockade and improved survival across multiple tumor types.

DOI 10.64898/2026.08.27.747587

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintOct 17, 2024

DeepVul: A Multi-Task Transformer Model for Joint Prediction of Gene Essentiality and Drug Response

Ala Jararweh, My Nguyen Bach, David Arredondo…·Avinash D Sahu

DeepVul predicts gene essentiality and drug response using a multi-task transformer model trained on cancer transcriptome data, improving precision oncology by identifying treatment vulnerabilities.

DOI 10.1101/2024.10.17.618944

humanbulk RNA-seq

𝕏 PostBluesky